Influence of Modern Colon Hydrotherapy on Intestinal Transit
Launched by UNIVERSIDAD COMPLUTENSE DE MADRID · May 26, 2024
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the effects of a treatment called Modern Colon Hydrotherapy on people who suffer from functional constipation, which is a long-term issue with bowel movements. The goal is to see if this therapy can help improve how quickly food and waste move through the digestive system. The trial is not yet recruiting participants, but it will involve adults aged 20 to 60 who have experienced functional constipation for more than five years.
To be eligible for this trial, participants should not have taken antibiotics, prebiotics, probiotics, or laxatives in the past month, and they should not be pregnant or have certain serious medical conditions like severe gastrointestinal issues or heart problems. If you join the trial, you can expect to receive treatment and contribute to important research that may help others with similar digestive issues in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients between 20 and 60 years of age with functional constipation of more than 5 years of evolution.
- Exclusion Criteria:
- • Taking any type of antibiotic in the last month
- • Taking prebiotics or probiotics products in the last month.
- • Taking laxatives in the last month.
- • Undergoing any medicinal treatment
- • Pregnancy
- • Subject with a history of current gastrointestinal pathology or disorder such as: acute colon pathology, acute haemorrhagic colitis, suspected digestive perforation, recent abdominal surgery, severe arterial hypertension, abdominal hernia, colon neoplasia, history of cardiac syncope, renal failure, liver cirrhosis, epilepsy, severe psychiatric illness (psychosis), necrosis due to abdominal irradiation, severe anaemia, severe neurovegetative lability.
About Universidad Complutense De Madrid
The Universidad Complutense de Madrid (UCM) is a prestigious academic institution renowned for its commitment to research and innovation in various fields, including health sciences. As a prominent sponsor of clinical trials, UCM leverages its extensive resources and expertise to advance medical knowledge and improve patient outcomes. The university fosters collaboration among researchers, clinicians, and industry partners, ensuring the highest standards of ethics and scientific rigor in its clinical research initiatives. UCM's dedication to education and research excellence positions it as a leader in the development of new therapeutic interventions and health solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Patients applied
Trial Officials
Isidro Fernández-López, PhD.
Principal Investigator
Universidad Complutense de Madrid
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported